formaldehyde has been researched along with Coronary Disease in 9 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In view of recent findings of nasal cancer in rats exposed to formaldehyde vapors, we investigated the proportionate mortality experience of embalmers licensed to practice in New York State." | 1.27 | Mortality patterns among embalmers. ( Fraumeni, JF; Walrath, J, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murugesan, SR | 1 |
| Gurbel, PA | 1 |
| Serebruany, VL | 2 |
| Fuzaylov, SY | 1 |
| Prickaerts, JP | 1 |
| Wilson, GJ | 1 |
| Bayliss, CE | 1 |
| Baffour, R | 1 |
| Walrath, J | 1 |
| Fraumeni, JF | 1 |
| Rozvadovskiĭ, VD | 1 |
| Muzykantskiĭ, EL | 1 |
| Myslovatyĭ, BS | 1 |
| Sekamova, SM | 1 |
| Ugriumov, AI | 1 |
| Kiyama, H | 1 |
| Ohshima, N | 1 |
| Sakurada, M | 1 |
| Kagawa, N | 1 |
| Imazeki, T | 1 |
| Yamada, T | 1 |
| Ahmed, AA | 1 |
| Mahadevan, VS | 1 |
| Webb, SW | 1 |
| MacGowan, SW | 1 |
| Fuchs, J | 1 |
| Weinberger, I | 1 |
| Rotenberg, Z | 1 |
| Joshua, H | 1 |
| Almozlino, A | 1 |
| Agmon, J | 1 |
| Kyösola, K | 1 |
| Waris, T | 1 |
| Penttilä, O | 1 |
| Ahonen, A | 1 |
| Penttilä, A | 1 |
| Mattila, T | 1 |
| Järvinen, A | 1 |
1 trial available for formaldehyde and Coronary Disease
| Article | Year |
|---|---|
Storing paraformaldehyde-fixed whole blood patient samples after chronic platelet glycoprotein IIb/IIIa blockade: core laboratory considerations.
Topics: Blood Preservation; Coronary Disease; Fixatives; Formaldehyde; Humans; Laboratories; Platelet Glycop | 1999 |
8 other studies available for formaldehyde and Coronary Disease
| Article | Year |
|---|---|
Amount of paraformaldehyde for sample fixation markedly affects the quality of platelet assessment by flow cytometry: experience from two clinical trials.
Topics: Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Fixat | 2000 |
Influence of fixative osmolality on the morphometric determination of extracellular space in normal and reperfused ischaemic myocardium.
Topics: Animals; Coronary Disease; Extracellular Space; Fixatives; Formaldehyde; Glutaral; Male; Myocardium; | 1984 |
Mortality patterns among embalmers.
Topics: Adult; Age Factors; Aged; Colonic Neoplasms; Coronary Disease; Embalming; Formaldehyde; Humans; Lung | 1983 |
[Experimental protection of the myocardium from anoxic damage by a weak solution of formalin].
Topics: Animals; Chinchilla; Coronary Disease; Formaldehyde; Heart; Heart Transplantation; Organ Preservatio | 1981 |
[A case of progressive right coronary ostial stenosis after Carrel patch method using gelatin-resorcin-formalin glue].
Topics: Adult; Blood Vessel Prosthesis Implantation; Coronary Disease; Coronary Vessels; Drug Combinations; | 1998 |
Glue aortoplasty repair of aortic dissection after coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aortic Aneurysm; Aortic Dissection; Coronary Disease; Drug Combinati | 2001 |
Circulating aggregated platelets in coronary artery disease.
Topics: Angina Pectoris; Angina, Unstable; Blood Platelets; Coronary Disease; Edetic Acid; Female; Formaldeh | 1987 |
Multi-score estimation of catecholamine fluorescence for clinical purposes.
Topics: Catecholamines; Coronary Disease; Flow Cytometry; Formaldehyde; Glyoxylates; Heart Failure; Heart Se | 1985 |